Prostate cancer in men of African origin

被引:94
作者
McGinley, Kathleen F. [1 ]
Tay, Kae Jack [1 ]
Moul, Judd W. [1 ]
机构
[1] Duke Univ, Dept Surg, Div Urol, DUMC 3707, Durham, NC 27710 USA
关键词
QUALITY-OF-LIFE; ANDROGEN RECEPTOR CAG; CAUCASIAN-AMERICAN MEN; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; RACIAL-DIFFERENCES; RADIATION-THERAPY; CLINICAL PRESENTATION; SUSCEPTIBILITY LOCUS; REPEAT LENGTH;
D O I
10.1038/nrurol.2015.298
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Men of African origin are disproportionately affected by prostate cancer: prostate cancer incidence is highest among men of African origin in the USA, prostate cancer mortality is highest among men of African origin in the Caribbean, and tumour stage and grade at diagnosis are highest among men in sub-Saharan Africa. Socioeconomic, educational, cultural, and genetic factors, as well as variations in care delivery and treatment selection, contribute to this cancer disparity. Emerging data on single-nucleotide-polymorphism patterns, epigenetic changes, and variations in fusion-gene products among men of African origin add to the understanding of genetic differences underlying this disease. On the diagnosis of prostate cancer, when all treatment options are available, men of African origin are more likely to choose radiation therapy or to receive no definitive treatment than white men. Among men of African origin undergoing surgery, increased rates of biochemical recurrence have been identified. Understanding differences in the cancer-survivorship experience and quality-of-life outcomes among men of African origin are critical to appropriately counsel patients and improve cultural sensitivity. Efforts to curtail prostate cancer screening will likely affect men of African origin disproportionately and widen the racial disparity of disease.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 125 条
  • [1] Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center
    Abern, M. R.
    Bassett, M. R.
    Tsivian, M.
    Banez, L. L.
    Polascik, T. J.
    Ferrandino, M. N.
    Robertson, C. N.
    Freedland, S. J.
    Moul, J. W.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (01) : 84 - 89
  • [2] Lack of Reduction in Racial Disparities in Cancer-Specific Mortality Over a 20-Year Period
    Aizer, Ayal A.
    Wilhite, Tyler J.
    Chen, Ming-Hui
    Graham, Powell L.
    Choueiri, Toni K.
    Hoffman, Karen E.
    Martin, Neil E.
    Quoc-Dien Trinh
    Hu, Jim C.
    Nguyen, Paul L.
    [J]. CANCER, 2014, 120 (10) : 1532 - 1539
  • [3] ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain
    Amann, JM
    Nip, J
    Strom, DK
    Lutterbach, B
    Harada, H
    Lenny, N
    Downing, JR
    Meyers, S
    Hiebert, SW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (19) : 6470 - 6483
  • [4] Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven
    Attard, Gerhardt
    Reid, Alison H. M.
    Olmos, David
    de Bono, Johann S.
    [J]. CANCER RESEARCH, 2009, 69 (12) : 4937 - 4940
  • [5] Chromosome 8 Markers of Metastatic Prostate Cancer in African American Men: Gain of the MIR151 Gene and Loss of the NKX3-1 Gene
    Barnabas, Nandita
    Xu, Lihua
    Savera, Adnan
    Hou, Zizheng
    Barrack, Evelyn R.
    [J]. PROSTATE, 2011, 71 (08) : 857 - 871
  • [6] Racial Variation in the Quality of Surgical Care for Prostate Cancer
    Barocas, Daniel A.
    Gray, Darryl T.
    Fowke, Jay H.
    Mercaldo, Nathaniel D.
    Blume, Jeffrey D.
    Chang, Sam S.
    Cookson, Michael S.
    Smith, Joseph A., Jr.
    Penson, David F.
    [J]. JOURNAL OF UROLOGY, 2012, 188 (04) : 1279 - 1285
  • [7] Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines
    Beilin, J
    Ball, EMA
    Favaloro, JM
    Zajac, JD
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (01) : 85 - 96
  • [8] Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status
    Bennett, CL
    Price, DK
    Kim, S
    Liu, D
    Jovanovic, BD
    Nathan, D
    Johnson, ME
    Montgomery, JS
    Cude, K
    Brockbank, JC
    Sartor, O
    Figg, WD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3599 - 3604
  • [9] Genetic polymorphism and prostate cancer aggressiveness: A case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans
    Bensen, Jeannette T.
    Xu, Zongli
    Smith, Gary J.
    Mohler, James L.
    Fontham, Elizabeth T. H.
    Taylor, Jack A.
    [J]. PROSTATE, 2013, 73 (01) : 11 - 22
  • [10] Hospice Use and High-Intensity Care in Men Dying of Prostate Cancer
    Bergman, Jonathan
    Saigal, Christopher S.
    Lorenz, Karl A.
    Hanley, Janet
    Miller, David C.
    Gore, John L.
    Litwin, Mark S.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (03) : 204 - 210